Odyssey Health (ODYY) R&D In Process (2021)
Odyssey Health has reported R&D In Process over the past 1 years, most recently at $9.4 million for Q2 2021.
- Quarterly results put R&D In Process at $9.4 million for Q2 2021, changed N/A from a year ago — trailing twelve months through Jul 2021 was $9.4 million (changed N/A YoY), and the annual figure for FY2021 was $9.4 million, changed.
- R&D In Process for Q2 2021 was $9.4 million at Odyssey Health.
- Over the last five years, R&D In Process for ODYY hit a ceiling of $9.4 million in Q2 2021 and a floor of $9.4 million in Q2 2021.